ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÖÜÖǻۣ©NOD2ÊÇ×ÔÈ»ÃâÒßϵͳÖÐÖ÷ÒªµÄϸ°ûÄÚģʽʶ±ðÊÜÌ壨PRR£©£¬£¬£¬Ëü¿ÉÒÔʶ±ð²¡ÔÏà¹ØµÄëľÛÌDz¢´¥·¢Ò»ÏµÁеĴÙÑ׺Ϳ¹¾úÃâÒß·´Ó³¡£¡£¡£NOD2ÐźŵÄʧµ÷Óë¶àÖÖÑ×Ö¢ÐÔ¼²²¡Ïà¹Ø£¬£¬£¬´ó×ÚÑо¿ÏÔʾNOD2µÄ¶à¸öÍ»±äÊǵ¼Ö¿ËÂÞ¶÷²¡¡¢Blau×ÛºÏÖ¢µÈ×ÔÉíÑ×Ö¢ÐÔ¼²²¡µÄÖ÷Òª·çÏÕÐÔÒòËØ¡£¡£¡£Òò´Ë£¬£¬£¬NOD2µÄ¼¤»î±ØÐè±»ÑÏ¿áµ÷¿Ø¡£¡£¡£S-רéµõ£»¯ÊÇÒ»ÖÖÐÂÐ͵ķÒëºóÐÞÊΣ¨PTM£©£¬£¬£¬¼ÓÈë¶àÖÖÂѰ׵Ķ¨Î»¡¢ÔËÊäºÍÎȹÌÐÔµ÷Àí¡£¡£¡£Ö»¹Ü×î½üÓÐÑо¿±¨µÀS-רéµõ£»¯ÐÞÊζÔNOD2µÄĤ¶¨Î»ºÍÆä½éµ¼µÄÐźÅͨ·¼¤»îÖÁ¹ØÖ÷Òª£¬£¬£¬µ«S-רéµõ£»¯¶ÔNOD2ÂѰ×ÎȹÌÐÔÊÇ·ñÓе÷Àí×÷ÓÃÉв»Ã÷È·¡£¡£¡£
¿ËÈÕ£¬£¬£¬ngµç×ÓÓÎÏ·ÉúÃü¿ÆÑ§Ñ§Ôº´ÞöÁ½ÌÊÚ¡¢½ðÊٺ㸱½ÌÊں͹ãÖÝÊи¾Å®¶ùͯҽÁÆÖÐÐÄÔø»ªËÉÖ÷ÈοÎÌâ×éÏàÖúÔÚCell Death & DifferentiationÔÓÖ¾ÉϽÒÏþÌâΪ¡°Palmitoylation restricts SQSTM1/p62-mediated autophagic degradation of NOD2 to modulate inflammation¡±µÄÑо¿ÂÛÎÄ£¬£¬£¬·¢Ã÷S-רéµõ£»¯Í¨¹ýÓëϸ°û×ÔÊɵĽ»»¥×÷Ó㬣¬£¬ÔÚµ÷¿ØNOD2 ÂѰ×ÎȹÌÐÔÖÐʩչÖ÷Òª¹¦Ð§£¬£¬£¬²¢Õ¹ÏÖÁË֮ǰ±»ºöÊÓµÄNOD2¶ÌÑÇÐÍ£¨NOD2s£©R444CÍ»±äͨ¹ýÔì³ÉS-רéµõ£»¯Ê§µ÷£¬£¬£¬±¬·¢Ì«¹ýÑ×Ö¢·´Ó³µÄлúÖÆ¡£¡£¡£
¸ÃÑо¿Á¬ÏµS-רéµõ£»¯ÒÖÖÆ¼Á2-bromopalmitate£¨2BP£©´¦Àí¡¢¹ý±í´ï/ÇõÍS-רéµõ£»¯Ã¸ZDHHC5ÒÔ¼°S-רéµõ£»¯ÐÞÊ樵ãÍ»±äµÈʵÑ飬£¬£¬Ö¤ÊµZDHHC5½éµ¼µÄS-רéµõ£»¯¿ÉÒÔÎȹÌNOD2ÂѰס£¡£¡£½øÒ»²½Ñо¿·¢Ã÷S-רéµõ£»¯Äܹ»ÒÖÖÆNOD2µÄ×ÔÊÉ;¾¶½µ½â¡£¡£¡£S-רéµõ£»¯Í¨¹ýÒÖÖÆ×ÔÊÉ»õÎïÊÜÌåSQSTM1/p62ÓëNOD2µÄÁ¬Ïµ£¬£¬£¬´Ó¶ø×è°NOD2½øÈë×ÔÊÉÈÜøÌå½µ½â£¬£¬£¬±»Îȹ̵ÄNOD2¿ÉÒÔ½øÒ»²½ÓÕµ¼Ñ×Ö¢·´Ó³¡£¡£¡£ÓÐÒâ˼µÄÊÇ£¬£¬£¬S-רéµõ£»¯ÐÞÊβ¢²»»áÓ°ÏìNOD2µÄ·ºËØ»¯ÐÞÊΣ¬£¬£¬Õ⸻ºñÁËÈËÃǶÔSQSTM1/p62ÒÀÀµÑ¡ÔñÐÔ×ÔÊɽµ½âËùÐèµ÷ÀíÐźŵÄÊìϤ¡£¡£¡£
±ðµÄ£¬£¬£¬¸ÃÑо¿»¹É¸Ñ¡·¢Ã÷NOD2¶ÌÑÇÐÍÖеÄR444CÍ»±ä£¨NOD2s-R444C£©¿ÉÒÔͨ¹ýÔö½øNOD2sµÄS-רéµõ£»¯ÒÔÔöÇ¿ÆäÎȹÌÐÔ£¬£¬£¬´Ó¶ø¼Ó¾çÑ×Ö¢·´Ó³£¬£¬£¬¿ÉÊÇNOD2³¤ÑÇÐÍÖжÔÓ¦µÄÍ»±ä£¨NOD2l-R471C£©È´¶ÔNOD2µÄS-רéµõ£»¯¼°½éµ¼µÄÑ×֢ûÓÐÓ°Ïì¡£¡£¡£½øÒ»²½µÄ»úÖÆÑо¿Åú×¢£¬£¬£¬ÕâÊÇÓÉÓÚNOD2s-R444CÍ»±äÔöÇ¿NOD2sÓëZDHHC5µÄÁ¬Ïµ£¬£¬£¬¶øNOD2l-R471CÍ»±ä²¢²»Ó°Ïì¶þÕßµÄÁ¬Ïµ£¨Í¼1£©¡£¡£¡£ÒÖÖÆNOD2s-R444CµÄרéµõ£»¯£¬£¬£¬¿ÉÏû³ý¸ÃÍ»±äµ¼ÖµÄÌ«¹ýÑ×Ö¢·´Ó³¡£¡£¡£ÓÉÓÚNOD2µÄR471C/R444CÍ»±äÔÚÑÇÖÞÈËȺÖÐÆµÂʽϸߣ¬£¬£¬ÇÒÔÚÑ×Ö¢ÐÔ³¦²¡£¡£¡£¨IBD£©µÈ×ÔÉíÑ×Ö¢ÐÔ¼²²¡»¼ÕßÌåÄÚ±»¶à´Î·¢Ã÷£¬£¬£¬¸ÃÑо¿½«ÓÐÖúÓÚNOD2Í»±äÏà¹ØµÄ×ÔÉíÑ×Ö¢ÐÔ¼²²¡»¼ÕßµÄÕï¶ÏºÍ׼ȷÖÎÁÆ¡£¡£¡£¼øÓÚרéµõ£»¯¶ÔNOD2ÂѰ׼¤»îºÍÎȹÌÐÔµÄÖ÷ÒªÐÔ£¬£¬£¬ÌØÒì°ÐÏòרéµõ£»¯Ã¸µÄÒ©Îï¿ÉÄÜÊÇÖÎÁÆ×ÔÉíÑ×Ö¢ÐÔ¼²²¡µÄÀíÏë°Ðµã¡£¡£¡£

ͼ1 Òì³£µÄS-רéµõ£»¯ÒÖÖÆSQSTM1/p62½éµ¼µÄNOD2×ÔÊɽµ½â£¬£¬£¬Ôö½øÑ×Ö¢·´Ó³
ngµç×ÓÓÎÏ·ÉúÃü¿ÆÑ§Ñ§Ôº´ÞöÁ½ÌÊÚ¡¢½ðÊٺ㸱½ÌÊں͹ãÖÝÊи¾Å®¶ùͯҽÁÆÖÐÐÄÔø»ªËɽÌÊÚΪ¸ÃÏîÊÂÇéµÄÅäºÏͨѶ×÷Õߣ¬£¬£¬ngµç×ÓÓÎÏ·ÉúÃü¿ÆÑ§Ñ§ÔºµÄ²©Ê¿ºóÖÜÖǻۺÍ˶ʿÑо¿ÉúºÎÐÇΪÅäºÏµÚÒ»×÷Õß¡£¡£¡£¸ÃÑо¿»ñµÃÁ˹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðµÈÏîÄ¿×ÊÖú¡£¡£¡£
ÂÛÎÄÁ´½Ó£ºhttps://doi.org/10.1038/s41418-022-00942-z